If you’ve ever had a sick dog, then you know how heartbreaking it can be to see them get treatment. That’s your baby! Hopefully your dog will take it in stride like one Golden Retriever, who bravely ...

DAYTON — News Center 7 morning anchor Nick Foley provided an update on his Multiple Myeloma treatment and said his first cycle of chemo is behind him. Foley said he will have a week off before his ...

“My first round of chemo experience was one of the worst things I've done ever in my entire life,” the 19-year-old said after being diagnosed with a brain tumor Michael Strahan's daughter Isabella ...

As she settled into the big chair at the medical center to have poison pumped into a port in her chest for the first time, Angie Budnick wondered: Would the chemotherapy make her sick? What about her ...

Enfortumab vedotin plus pembrolizumab not only beat chemotherapy in the first-line setting for locally advanced metastatic urothelial cancer for the first time in decades, but it nearly doubled ...

Michael Strahan’s daughter Isabella is giving insight into her recent multi-day hospitalization after coming down with a fever following her first round of chemotherapy. “It’s my third day here. I got ...

Credit: Getty Images. Phase 3 trial results support atezolizumab as a potential first-line treatment option for patients with advanced non-small cell lung cancer. Phase 3 trial results support ...

Changing the standard sequence of treatment for operable pancreatic cancer could improve survival for some patients, say researchers. Some patients with operable disease and elevated levels of the CA ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." From the “Sultan of Swat” to the “Colossus of Clout,” no baseball player has inspired more ...

Chemotherapy has long been a cornerstone of treatment when it comes to fighting cancer. Although it has proven efficacy in fighting the disease, its toll on patients both mentally and physically ...

Overall survival was statistically significantly improved in adults treated with tislelizumab/chemotherapy compared with placebo/chemotherapy. The Food and Drug ...

The National Institute for Health and Care Excellence (NICE) has recommended amivantamab (Rybrevant) plus lazertinib ...